Follow us for updates
© 2021 reportr.world
Read the Story →

U.S. to Authorize Pfizer Vaccine for Ages 12 and Up: Report

For ages 12 and up.
by Agence France Presse
Just now
Photo/s: Shutterstock
Shares

WASHINGTON -- The United States is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for children age 12 and up by early next week, U.S. media reported Monday.

Pfizer has applied for emergency use authorization for its COVID-19 vaccine for children and teenagers between ages 12 and 15, according to CNN, citing a government official.

"The FDA will have to amend the emergency use authorization for the vaccine, but the process should be straightforward," CNN reported.

The U.S. Food and Drug Administration is expected to grant that approval by early next week. After the FDA decision, the Centers for Disease Control and Prevention advisory committee will meet to recommend how the vaccine should be used.

A spokeswoman for the FDA declined to give details on the approval timeline, telling The Washington Post: "We are working to review this request as quickly and transparently as possible."

The Pfizer vaccine is currently authorized for people 16 and older in the United States.

Continue reading below ↓

The U.S. pharmaceutical giant said in late March it had submitted data from a clinical trial of 2,260 12- to 15-year-olds that showed the vaccine was highly effective and well-tolerated.

Further testing on younger children is ongoing.

Moderna is conducting trials of its vaccine in teens, with results expected in the summer, as well as in younger children.

Continue reading below ↓
Recommended Videos

Johnson & Johnson is also planning pediatric trials for its vaccine.

MORE ON VACCINES

Pfizer COVID-19 Vaccine: What You Need to Know

Moderna's COVID Vaccine Gets WHO Approval for Emergency Use

Expanding vaccine authorization to include adolescents could open up the US mass vaccination program to millions more people.

The national vaccination rate peaked around April 11, according to official data, and although 55% of U.S. adults now have had one or more doses, there's still a long way to go to achieve population immunity against COVID-19.

The people most eager to get their shots have, for the most part, already rolled up their sleeves and done so.

Continue reading below ↓

But vaccine hesitancy remains a major obstacle: a large percentage of U.S. adults don't plan to get the shot and could potentially refuse to get their children vaccinated.

Among Republican voters, 29% say they will never take the vaccine, compared to 5% of Democrats and 9% of independents, according to a recent survey by the Kaiser Family Foundation. 

Reportr is now on Quento. Download the app on iOS and Android or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.